Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Tax Provisions (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Tax Provisions for 6 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 16.48% year-over-year to $2.2 million, compared with a TTM value of $6.4 million through Dec 2025, up 34.24%, and an annual FY2025 reading of $6.4 million, up 34.24% over the prior year.
  • Tax Provisions was $2.2 million for Q4 2025 at Viemed Healthcare, up from $1.5 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.2 million in Q4 2025 and bottomed at -$223000.0 in Q1 2021.
  • Average Tax Provisions over 5 years is $1.1 million, with a median of $1.1 million recorded in 2021.
  • Peak annual rise in Tax Provisions hit 541.06% in 2021, while the deepest fall reached 219.25% in 2021.
  • Year by year, Tax Provisions stood at $968000.0 in 2021, then grew by 18.39% to $1.1 million in 2022, then surged by 39.53% to $1.6 million in 2023, then grew by 17.64% to $1.9 million in 2024, then increased by 16.48% to $2.2 million in 2025.
  • Business Quant data shows Tax Provisions for VMD at $2.2 million in Q4 2025, $1.5 million in Q3 2025, and $1.7 million in Q2 2025.